These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23409936)

  • 21. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency.
    Cheng Y; Shen J; Peng RZ; Wang GF; Zuo JP; Long YQ
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2900-2906. PubMed ID: 27133482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay.
    Stammers TA; Coulombe R; Duplessis M; Fazal G; Gagnon A; Garneau M; Goulet S; Jakalian A; LaPlante S; Rancourt J; Thavonekham B; Wernic D; Kukolj G; Beaulieu PL
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6879-85. PubMed ID: 24176401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.
    Zhao C; Wang Y; Ma S
    Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus.
    Chen YL; Tang J; Kesler MJ; Sham YY; Vince R; Geraghty RJ; Wang Z
    Bioorg Med Chem; 2012 Jan; 20(1):467-79. PubMed ID: 22100256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase.
    Kukolj G; McGibbon GA; McKercher G; Marquis M; Lefèbvre S; Thauvette L; Gauthier J; Goulet S; Poupart MA; Beaulieu PL
    J Biol Chem; 2005 Nov; 280(47):39260-7. PubMed ID: 16188890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G; Küçükgüzel İ; Guhamazumder R; Tatar E; Manvar D; Basu A; Patel BA; Zia J; Talele TT; Kaushik-Basu N
    Arch Pharm (Weinheim); 2015 Jan; 348(1):10-22. PubMed ID: 25449674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B.
    Liu M; Xu Q; Guo S; Zuo R; Hong Y; Luo Y; Li Y; Gong P; Liu Y
    Bioorg Med Chem; 2018 May; 26(9):2621-2631. PubMed ID: 29681484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.
    Harikishore A; Li E; Lee JJ; Cho NJ; Yoon HS
    Mol Divers; 2015 Aug; 19(3):529-39. PubMed ID: 25862642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
    Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
    J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel HCV polymerase inhibitors using pharmacophore-based virtual screening.
    Kim ND; Chun H; Park SJ; Yang JW; Kim JW; Ahn SK
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3329-34. PubMed ID: 21531135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.
    Nyanguile O; Pauwels F; Van den Broeck W; Boutton CW; Quirynen L; Ivens T; van der Helm L; Vandercruyssen G; Mostmans W; Delouvroy F; Dehertogh P; Cummings MD; Bonfanti JF; Simmen KA; Raboisson P
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4420-31. PubMed ID: 18852280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
    Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
    J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; Omar FA
    Eur J Med Chem; 2019 Dec; 184():111747. PubMed ID: 31604164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors.
    Ontoria JM; Rydberg EH; Di Marco S; Tomei L; Attenni B; Malancona S; Martin Hernando JI; Gennari N; Koch U; Narjes F; Rowley M; Summa V; Carroll SS; Olsen DB; De Francesco R; Altamura S; Migliaccio G; Carfì A
    J Med Chem; 2009 Aug; 52(16):5217-27. PubMed ID: 19877603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor.
    Paparin JL; Amador A; Badaroux E; Bot S; Caillet C; Convard T; Da Costa D; Dukhan D; Griffe L; Griffon JF; LaColla M; Leroy F; Liuzzi M; Giulia Loi A; McCarville J; Mascia V; Milhau J; Onidi L; Pierra C; Rahali R; Rosinosky E; Sais E; Seifer M; Surleraux D; Standring D; Dousson CB
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2634-2640. PubMed ID: 28416131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of novel HCV replication inhibitors.
    McGowan DC; Khamlichi MD; De Groot A; Pauwels F; Delouvroy F; Van Emelen K; Simmen K; Raboisson P
    Mol Divers; 2017 May; 21(2):475-481. PubMed ID: 28293834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT
    Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.